AstraZeneca – Interim Target A

Emissions reduction target
Description of Interim Target

“Through our flagship $1 billion Ambition Zero Carbon programme we are on track to reduce greenhouse gas emissions from our global operations (Scope 1 and 2) by 98% by 2026 (from 2015 baseline) and halve our entire value chain footprint by 2030 on the way to a 90% reduction by 2045 (from 2019 baseline).”

  • Interim Target Baseline Year: 2015
% reductions committed to
Interim Target
Emissions reduction target
Baseline Emissions